Welcome to CDC Stacks | Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season - 33116 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season
Filetype[PDF - 205.00 KB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.) ; National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. ;
  • Series:
    MMWR. Morbidity and mortality weekly report, Vol. 63, no. 32, p. 691-7
  • Document Type:
  • Description:
    This report updates the 2013 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding use of seasonal influenza vaccines. Updated information for the 2014-15 influenza season includes 1) antigenic composition of U.S. seasonal influenza vaccines; 2) vaccine dose considerations for children aged 6 months through 8 years; and 3) a preference for the use, when immediately available, of live attenuated influenza vaccine (LAIV) for healthy children aged 2 through 8 years, to be implemented as feasible for the 2014-15 season but not later than the 2015-16 season. Information regarding issues related to influenza vaccination not addressed in this report is available in the 2013 ACIP seasonal influenza recommendations.

    Recommendations for routine use of vaccines in children, adolescents, and adults are developed by the Advisory Committee on Immunization Practices (ACIP). ACIP is chartered as a federal advisory committee to provide expertexternal advice and guidance to the Director of the Centers for Disease Control and Prevention (CDC) on use of vaccines and related agents for the control of vaccine-preventable diseases in the civilian population of the United States. Recommendations for routine use of vaccines in children and adolescents are harmonized to the greatest extent possible with recommendations made by the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), and the American College of Obstetrics and Gynecology (ACOG). Recommendations for routine use of vaccines in adults are harmonized with recommendations of AAFP, ACOG, and the American College of hysicians (ACP). ACIP recommendations adopted by the CDC Director become agency guidelines on the date published in the Morbidity and Mortality Weekly Report (MMWR). Additional information regarding ACIP is available at http://www.cdc.gov/vaccines/acip.

    Citation: Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, Karron RA, Walter EB; Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep. 2014 Aug 15;63(32):691-7.

    PMID: 25121712

  • Supporting Files:
    No Additional Files
  1. Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014
  2. Prevention and control of influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season
  3. Prevention and control of influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011
  4. Prevention and control of influenza with vaccines; recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010
  5. Prevention and control of seasonal influenza with vaccines; recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
  6. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008
  7. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007
  8. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  9. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  10. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  11. Using live, attenuated influenza vaccine for prevention and control of influenza; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)
  12. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  13. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  14. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  15. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  16. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  17. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  18. Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)
  19. Prevention and control of influenza; recommendations of the Immunization Practices Advisory Committee (ACIP)
  20. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
  21. Prevention and control of influenza.
  22. Prevention and control of influenza.
  23. Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010--11. MMWR 2010; 59 (31): 989-992.
  24. Notice to Readers: Expansion of Use of Live Attenuated Influenza Vaccine (FluMist ) to Children Aged 2--4 Years and Other FluMist Changes for the 2007--08 Influenza Season. MMWR 2007. 56 (46): 1217-1219.